주요서비스 바로가기
본문 바로가기
매체정보 바로가기
로그인 바로가기
기사검색 바로가기
전체서비스 바로가기
Updated : Thursday, Aprill 25, 2024, 08:38
Home
Login
Sign in
한국어
National
Foreign Affairs
Central & Regional Affairs
Social Issues
Economics
Macro-Economics
Trade
Foreign Exchanges
Industries
ICT
Automobiles
Heavy & Chemical
Defence
Entertainment
Energy
Construction
Healthcare & Bio
Consumer
Services
Stock Market
Company & Stock Tracking
Market Trend & Outlook
Finance
Capital Market
Crypto
Banking
Insurances
Startups
Science/Tech
Science
New Tech
Blockchain
ESG
Environment
Social
Governance
Event
Exhibitions
Conferences
People
K-Culture
Cinema/Drama
K-pop
Food
Lifestyle
Arts/Culture
Opinion
Editorials
Contributions
Who's Who
기사검색
검색
All articles
List
Subject Type
Summary Type
Photo Type
Finance
Bio Industry: 2022 ASCO: Start Identifying Investment Opportunities via Selective Approach in 2H22
Park Pyeong-kuk
2022.05.30 13:58
Anti-AIDS Drug Candidate of KRICT Approved in China
Jung Suk-yee
2021.10.01 12:18
Yuhan: Main Business Recovering, Starting with Domestic Leclaza
Park Pyeong-kuk
2021.07.30 14:05
Finance
Bio Industry: Trends to Watch in 2H21: M&As, CMOs, and Proprietary Technologies
Park Pyeong-kuk
2021.06.10 10:44
Yuhan: Two Key Issues for Lazertinib
Yoon Young-sil
2021.03.18 10:43
LegoChem Biosciences: Gilead's Takeover of Immunomedics Highlights LegoChem's Value
Lee Dong-gun
2020.09.15 09:27
Finance
Spot Comment: Bio Industry: Big Pharma War Begins to Secure CD47 Antibodies
William Ku
2020.09.09 16:10
15 COVID-19 Clinical Trials Underway in South Korea
Choi Moon-hee
2020.08.12 09:16
Finance
Bio Industry (4): Promising Biotech Players
William Ku & Wei Han
2020.08.01 19:36
(2H20 Industry Outlook) Pharmaceutical/Bio: Further Benefits Expected from Global Spread of COVID-19
William Ku
2020.06.18 21:40
Finance
Bio Industry: Clinical Trial Update for Gilead's COVID-19 Treatment
William Ku
2020.03.13 14:06
Finance
Yuhan Co.: 4Q19 Review: Earnings Miss Consensus on Deferred Booking of Licensing Income
William Ku
2020.02.28 11:57
처음
1
끝
위로
모바일버전
All articles
National
전체
Foreign Affairs
Central & Regional Affairs
Social Issues
Economics
전체
Macro-Economics
Trade
Foreign Exchanges
Industries
전체
ICT
Automobiles
Heavy & Chemical
Defence
Entertainment
Energy
Construction
Healthcare & Bio
Consumer
Services
Stock Market
전체
Company & Stock Tracking
Market Trend & Outlook
Finance
전체
Capital Market
Crypto
Banking
Insurances
Startups
Science/Tech
전체
Science
New Tech
Blockchain
ESG
전체
Environment
Social
Governance
Event
전체
Exhibitions
Conferences
People
K-Culture
전체
Cinema/Drama
K-pop
Food
Lifestyle
Arts/Culture
Opinion
전체
Editorials
Contributions
Who's Who
전체메뉴닫기